Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis—A Cross-Sectional Study
Authors:
- Elias A. T. KochEKElias A. T. Koch
- Theresa SteebTSTheresa Steeb
- Sophia Bender-SäbelkampfSBSophia Bender-Säbelkampf
- Dorothee BuschDBDorothee Busch
- Janina FeustelJFJanina Feustel
- Matthias D. KaufmannMKMatthias D. Kaufmann
- Andreas MaronnaAMAndreas Maronna
- Christine MederCMChristine Meder
- Moritz RonickeMRMoritz Ronicke
- Frédéric ToussaintFTFrédéric Toussaint
- Hedwig WelleinHWHedwig Wellein
- Carola BerkingCBCarola Berking
Open Access
- 1 June 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3813
Abstract
Background: Many treatments for actinic keratosis (AK) have been proven efficient in clinical trials. However, patients with AK may still experience unsatisfactory therapeutic outcomes in clinical practice. Objectives: To investigate patient adherence to self-applied topical interventions for AK and to explore factors associated with adherence in a real-world setting. Methods: A cross-sectional study was conducted. Patients presenting with AK were asked to complete a self-administered questionnaire about their last topical AK treatment. Results: A total of 113 patients participated with a median age of 78.5 years (range 58–94). Fifty-four patients (47.8%) received topical diclofenac, ten (8.8%) imiquimod, nine (8%) 5-fluorouracil, nine (8%) 5-fluorouracil plus salicylic acid, and eight (7.1%) photodynamic therapy. The non-adherence rate was 46.9% (n = 53), and only 30.9% (n = 35) used the topical treatments according to the summary of product characteristics (SmPC). These subgroups were compared. Patients of the non-compliant group were significantly less informed about the application time of the specific topical intervention (p = 0.002) and adjusted the timeframe (p < 0.001) and application frequency of the therapy (p = 0.02) independently of their physician. Conversely, patients reporting a sufficient pre-treatment consultation (p = 0.019) generally complied with the SmPC compliance application. Conclusions: A thorough pre-treatment consultation can help to increase treatment adherence and ensure lesion clearance.Keywords
Funding Information
- German Society of Dermatology (DDG)
- Arbeitsgemeinschaft Dermatologische Forschung (ADF)
This publication has 41 references indexed in Scilit:
- Non-adherence to topical treatments for actinic keratosisPatient Preference and Adherence, 2013
- Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology GroupJournal of the European Academy of Dermatology and Venereology, 2011
- Actinic keratosesCancer, 2009
- Multicentre intraindividual randomized trial of topical methyl aminolaevulinate–photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremitiesBritish Journal of Dermatology, 2008
- Adherence to an exercise prescription scheme: The role of expectations, self‐efficacy, stage of change and psychological well‐beingBritish Journal of Health Psychology, 2005
- Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 casesBritish Journal of Dermatology, 2004
- Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histologyJournal of the American Academy of Dermatology, 2004
- Imiquimod: modes of actionBritish Journal of Dermatology, 2003
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Patient noncompliance with self-administered chemotherapyCancer, 1990